Search research articles
Contact Us
Filters
Showing results (11-20 of 35) with videos related to
Page
of 4
Sort By:
Journal of Pharmaceutical Sciences
|
March 10, 2026
Navigating ADME profiling challenges in microphysiological systems: Evaluation of a liver-chip model for clearance prediction
Lina Mettler, Julia Riede, Felix Huth, et al.
Brain Research
|
August 10, 2010
Cytokine signaling in the human brain capillary endothelial cell line hCMEC/D3
Elizaveta Fasler-Kan, Claudia Suenderhauf, Natasha Barteneva, et al.
Planta Medica
|
June 7, 2006
Hypericum perforatum: which constituents may induce intestinal MDR1 and CYP3A4 mRNA expression?
Heike Gutmann, Birk Poller, Karin Berger Büter, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
March 13, 2019
Examining P-gp efflux kinetics guided by the BDDCS - Rational selection of in vitro assay designs and mathematical models
Julia Riede, Ken-Ichi Umehara, Patrick Schweigler, et al.
Journal of Pharmaceutical Sciences
|
February 4, 2021
Predicting Oral Absorption for Compounds Outside the Rule of Five Property Space
Felix Huth, Norbert Domange, Birk Poller, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
February 2, 2011
Differential impact of P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2) on axitinib brain accumulation and oral plasma pharmacokinetics
Birk Poller, Dilek Iusuf, Rolf W Sparidans, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
February 15, 2024
Improving In Vitro-In Vivo Extrapolation of Clearance Using Rat Liver Microsomes for Highly Plasma Protein-Bound Molecules
Markus Trunzer, Joana Teigão, Felix Huth, et al.
Pharmacology, Biochemistry, and Behavior
|
April 25, 2012
In vitro P-glycoprotein efflux inhibition by atypical antipsychotics is in vivo nicely reflected by pharmacodynamic but less by pharmacokinetic changes
Ulrich Schmitt, Katrin M Kirschbaum, Birk Poller, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
January 13, 2012
P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2) restrict brain accumulation of the active sunitinib metabolite N-desethyl sunitinib
Seng Chuan Tang, Nienke A G Lankheet, Birk Poller, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
May 10, 2019
A Systematic In Vitro Investigation of the Inhibitor Preincubation Effect on Multiple Classes of Clinically Relevant Transporters
Péter Tátrai, Patrick Schweigler, Birk Poller, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 35) with videos related to
Sort By:
Page
of 4
Journal of Pharmaceutical Sciences
|
March 10, 2026
Navigating ADME profiling challenges in microphysiological systems: Evaluation of a liver-chip model for clearance prediction
Lina Mettler, Julia Riede, Felix Huth, et al.
Brain Research
|
August 10, 2010
Cytokine signaling in the human brain capillary endothelial cell line hCMEC/D3
Elizaveta Fasler-Kan, Claudia Suenderhauf, Natasha Barteneva, et al.
Planta Medica
|
June 7, 2006
Hypericum perforatum: which constituents may induce intestinal MDR1 and CYP3A4 mRNA expression?
Heike Gutmann, Birk Poller, Karin Berger Büter, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
March 13, 2019
Examining P-gp efflux kinetics guided by the BDDCS - Rational selection of in vitro assay designs and mathematical models
Julia Riede, Ken-Ichi Umehara, Patrick Schweigler, et al.
Journal of Pharmaceutical Sciences
|
February 4, 2021
Predicting Oral Absorption for Compounds Outside the Rule of Five Property Space
Felix Huth, Norbert Domange, Birk Poller, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
February 2, 2011
Differential impact of P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2) on axitinib brain accumulation and oral plasma pharmacokinetics
Birk Poller, Dilek Iusuf, Rolf W Sparidans, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
February 15, 2024
Improving In Vitro-In Vivo Extrapolation of Clearance Using Rat Liver Microsomes for Highly Plasma Protein-Bound Molecules
Markus Trunzer, Joana Teigão, Felix Huth, et al.
Pharmacology, Biochemistry, and Behavior
|
April 25, 2012
In vitro P-glycoprotein efflux inhibition by atypical antipsychotics is in vivo nicely reflected by pharmacodynamic but less by pharmacokinetic changes
Ulrich Schmitt, Katrin M Kirschbaum, Birk Poller, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
January 13, 2012
P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2) restrict brain accumulation of the active sunitinib metabolite N-desethyl sunitinib
Seng Chuan Tang, Nienke A G Lankheet, Birk Poller, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
May 10, 2019
A Systematic In Vitro Investigation of the Inhibitor Preincubation Effect on Multiple Classes of Clinically Relevant Transporters
Péter Tátrai, Patrick Schweigler, Birk Poller, et al.
Page
of 4